LncRNA在肿瘤转移和侵袭中的研究现状
Research Status of LncRNA in Tumor Metastasis and Invasion
DOI: 10.12677/ACM.2023.1371701, PDF,    科研立项经费支持
作者: 王金鹏:青海大学研究生院,青海 西宁;朱海宏*:青海省人民医院普外科,青海 西宁
关键词: LncRNA肿瘤转移侵袭LncRNA Tumor Metastasis Invasion
摘要: 长非编码RNA (Long non-coding RNA)是一类基因长度超过200个核苷酸的非编码RNA。近年来,随着二代测序技术的发展以及对人们对LncRNA的深入研究,发现了LncRNA通过作为肿瘤的癌基因或抑制因子发挥着双重作用,即促进肿瘤或者抑制肿瘤。LncRNA现已被证明参与各种生物过程,如细胞生长、抗凋亡、转移和侵袭。最近许多研究发现LncRNA在各种恶性肿瘤中显著异常表达,包括肝癌、胰腺癌、胃癌和肺癌等。本文综述将从在国内外研究中LncRNA与肿瘤的转移和侵袭等生物学行为以及预后作一概述,以期为这些肿瘤提供新治疗的思路。
Abstract: Long non-coding RNA (LncRNA) is a class of non-coding RNAs with a gene length of more than 200 nucleotides. In recent years, with the development of second-generation sequencing technology and in-depth studies on LncRNA, it has been found that LncRNA plays a dual role as an oncogene or suppressor of tumor, that is, promoting tumor or inhibiting tumor. LncRNAs have now been shown to be involved in various biological processes, such as cell growth, anti-apoptosis, metastasis, and invasion. Recently, many studies have found that LncRNA is significantly and abnormally expressed in various malignant tumors, including liver cancer, pancreatic cancer, gastric cancer and lung can-cer. This review will summarize the relationship between LncRNA and tumor metastasis, invasion and other biological behaviors as well as prognosis in domestic and foreign studies, in order to pro-vide new treatment ideas for these tumors.
文章引用:王金鹏, 朱海宏. LncRNA在肿瘤转移和侵袭中的研究现状[J]. 临床医学进展, 2023, 13(7): 12136-12143. https://doi.org/10.12677/ACM.2023.1371701

参考文献

[1] Wang, X., et al. (2022) LncRNA LINC00460: Function and Mechanism in Human Cancer. Thoracic Cancer, 13, 3-14. [Google Scholar] [CrossRef] [PubMed]
[2] Toden, S., Zumwalt, T.J. and Goel, A. (2021) Non-Coding RNAs and Potential Therapeutic Targeting in Cancer. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1875, Article ID: 188491. [Google Scholar] [CrossRef] [PubMed]
[3] Iyer, M.K., Niknafs, Y.S., Malik, R., et al. (2015) The Land-scape of Long Noncoding RNAs in the Human Transcriptome. Nature Genetics, 47, 199-208. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, L., He, M., Zhang, M., et al. (2021) The Role of Non-Coding RNAs in Colorectal Cancer, with a Focus on Its Autophagy. Pharmacology & Therapeutics, 226, Article ID: 107868. [Google Scholar] [CrossRef] [PubMed]
[5] Liao, Y., Wu, X., Wu, M., et al. (2022) Non-Coding RNAs in Lung Cancer: Emerging Regulators of Angiogenesis. Journal of Translational Medicine, 20, 349. [Google Scholar] [CrossRef] [PubMed]
[6] Liu, Y., Leng, P., Liu, Y., Guo, J., et al. (2022) Crosstalk be-tween Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications. International Journal of Molecular Sciences, 23, Article No. 15759. [Google Scholar] [CrossRef] [PubMed]
[7] Cao, J., Zhang, M., Zhang, L., et al. (2021) Non-Coding RNA in Thyroid Cancer—Functions and Mechanisms. Cancer Letters, 496, 117-126. [Google Scholar] [CrossRef] [PubMed]
[8] Shi, X., Sun, M., Liu, H., et al. (2013) Long Non-Coding RNAs: A New Frontier in the Study of Human Diseases. Cancer Letters, 339, 159-166. [Google Scholar] [CrossRef] [PubMed]
[9] Ashrafizadeh, M., Rabiee, N., Kumar, A.P., et al. (2022) Long Noncoding RNAs (lncRNAs) in Pancreatic Cancer Progression. Drug Discovery Today, 27, 2181-2198. [Google Scholar] [CrossRef] [PubMed]
[10] 曾慧娟, 王璐璐, 等. 长链非编码RAN与乳腺癌治疗耐药相关的研究进展[J]. 医学研究生学报, 2017, 30(12): 1340-1344.
[11] Chi, Y., Wang, D., Wang, J., et al. (2019) Long Non-Coding RNA in the Pathogenesis of Cancers. Cells, 8, 1015. [Google Scholar] [CrossRef] [PubMed]
[12] Kapranov, P., St Laurent, G., Raz, T., et al. (2010) The Majority of Total Nuclear-Encoded Non-Ribosomal RNA in a Human Cell Is “Dark Matter” Un-Annotated RNA. BMC Biology, 8, Article No. 149. [Google Scholar] [CrossRef] [PubMed]
[13] Zhao, K.L., Zhou, X.Q., Xiao, Y.C., et al. (2022) Research Progress in Alpha-Fetoprotein-Induced Immunosuppression of Liver Cancer. Mini-Reviews in Medicinal Chemistry, 22, 2237-2243. [Google Scholar] [CrossRef] [PubMed]
[14] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[15] 曹毛毛, 李贺, 孙殿钦, 何思怡, 等. 全球肝癌2020年流行病学现状[J]. 中华肿瘤防治杂志, 2022(5): 322-328.
[16] Attwa, M.H. and El-Etreby, S.A. (2015) Guide for Diagnosis and Treatment of Hepatocellular Carcinoma. World Journal of Hepatology, 7, 1632-1651. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, J.G. and Zhang, S.W. (2011) Liver Cancer Epidemic in China: Past, Present and Future. Seminars in Cancer Biology, 21, 59-69. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, Y., Li, K., Dai, T., Wang, H., et al. (2021) Long Non-Coding RNA HCP5 Functions as a Sponge of miR-29b-3p and Promotes Cell Growth and Metastasis in Hepato-cellular Carcinoma through Upregulating DNMT3A. Aging (Albany NY), 13, 16267-16286. [Google Scholar] [CrossRef] [PubMed]
[19] Sayad, A., Najafi, S., Hussen, B.M., et al. (2022) The Emerging Roles of the β-Secretase BACE1 and the Long Non- Coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegen-erative Diseases and Cancer. Frontiers in Aging Neuroscience, 14, Article ID: 853180. [Google Scholar] [CrossRef] [PubMed]
[20] Liu, C., Wang, H., Tang, L., et al. (2021) LncRNA BACE1-AS Enhances the Invasive and Metastatic Capacity of Hepatocellular Carcinoma Cells through Mediating miR-377-3p/CELF1 Axis. Life Sciences, 275, Article ID: 119288. [Google Scholar] [CrossRef] [PubMed]
[21] Tian, Q., Yan, X., Yang, L., Liu, Z., et al. (2021) Long Non-Coding RNA BACE1-AS Plays an Oncogenic Role in Hepatocellular Carcinoma Cells through miR-214-3p/APLN Axis. Acta Biochimica et Biophysica Sinica (Shanghai), 53, 1538-1546. [Google Scholar] [CrossRef] [PubMed]
[22] Azizidoost, S., Nasrolahi, A., Ghaedrahmati, F., et al. (2022) The Pathogenic Roles of lncRNA-Taurine Upregulated 1 (TUG1) in Colorectal Cancer. Cancer Cell International, 22, 335. [Google Scholar] [CrossRef] [PubMed]
[23] Li, K., Niu, H., Wang, Y., Li, R., et al. (2021) LncRNA TUG1 Contributes to the Tumorigenesis of Lung Adenocarcinoma by Regulating miR-138-5p-HIF1A Axis. International Journal of Immunopathology and Pharmacology, 35. [Google Scholar] [CrossRef] [PubMed]
[24] Li, W., Ge, J.Z., Xie, J.J., et al. (2021) LncRNA TUG1 Pro-motes Hepatocellular Carcinoma Migration and Invasion via Targeting the miR-137/AKT2 Axis. Cancer Biotherapy and Radiopharmaceuticals, 36, 850-862. [Google Scholar] [CrossRef] [PubMed]
[25] He, C., Liu, Z., Jin, L., Zhang, F., et al. (2018) LncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1. Cellular Physiology & Biochemistry, 48, 1928-1941. [Google Scholar] [CrossRef] [PubMed]
[26] Panzitt, K., Tschernatsch, M.M., Guelly, C., et al. (2007) Characterization of HULC a Novel Gene with Striking Up- Regulation in Hepatocellular Carcinoma as Noncoding RNA. Gastroenterol-ogy, 132, 330-342. [Google Scholar] [CrossRef] [PubMed]
[27] Li, D., Liu, X., Zhou, J., et al. (2017) Long Noncoding RNA HULC Modulates the Phosphorylation of YB-1 through Serving as a Scaffold of Extracellular Signal-Regulated Kinase and YB-1 to Enhance Hepatocarcinogenesis. Hepatology, 65, 1612-1627. [Google Scholar] [CrossRef] [PubMed]
[28] Li, S.P., Xu, H.X., Yu, Y., et al. (2016) LncRNA HULC Enhances Epithe-lial-Mesenchymal Transition to Promote Tumorigenesis and Metastasis of Hepatocellular Carcinoma via the miR-200a-3p/ZEB1 Signaling Pathway. Oncotarget, 7, 42431-42446. [Google Scholar] [CrossRef] [PubMed]
[29] Li, X.M., et al. (2020) Long Non-Coding RNA MIAT Promotes Gastric Cancer Proliferation and Metastasis via Modulating the miR-331-3p/RAB5B Pathway. Oncology Letters, 20, 355. [Google Scholar] [CrossRef] [PubMed]
[30] Ren, Z., et al. (2020) Long Non-Coding RNA DDX11-AS1 Facilitates Gastric Cancer Progression by Regulating miR- 873-5p/SPC18 Axis. Artificial Cells, Nanomedicine, and Biotechnology, 48, 572-583. [Google Scholar] [CrossRef] [PubMed]
[31] Sieges, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Sta-tistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
[32] Deplanque, G. and Demartines, N. (2017) Pancreatic Cancer: Are More Chemotherapy and Surgery Needed? The Lancet, 389, 985-986. [Google Scholar] [CrossRef
[33] Kindler, H.L. (2018) A Glimmer of Hope for Pancreatic Cancer. The New England Journal of Medicine, 379, 2463- 2464. [Google Scholar] [CrossRef
[34] Schmitt, A.M. and Chang, H.Y. (2016) Long Noncoding RNAs in Cancer Pathways. Cancer Cell, 29, 452-463. [Google Scholar] [CrossRef] [PubMed]
[35] Eldesouki, S., Samara, K.A., Qadri, R., Obaideen, A.A., Otour, A.H., Habbal, O. and Bm Ahmed, S. (2022) XIST in Brain Cancer. Clinica Chimica Acta, 531, 283-290. [Google Scholar] [CrossRef] [PubMed]
[36] Shen, J., Hong, L., Yu, D., et al. (2019) LncRNA XIST Promotes Pancreatic Cancer Migration, Invasion and EMT by Sponging miR-429 to Modulate ZEB1 Expression. The International Journal of Biochemistry & Cell Biology, 113, 17-26. [Google Scholar] [CrossRef] [PubMed]
[37] Hao, Z., Dang, W., Zhu, Q., et al. (2023) Long Non-Coding RNA UCA1 Regulates MPP-Induced Neuronal Damage through the miR-671-5p/KPNA4 Pathway in SK-N-SH Cells. Metabolic Brain Disease, 38, 961-972. [Google Scholar] [CrossRef] [PubMed]
[38] Zhou, Y., Chen, Y., Ding, W., et al. (2018) LncRNA UCA1 Impacts Cell Proliferation, Invasion, and Migration of Pancreatic Cancer through Regulating miR-96/FOXO3. IUBMB Life, 70, 276-290. [Google Scholar] [CrossRef] [PubMed]
[39] Zhang, M., Zhao, Y., Zhang, Y., et al. (2018) LncRNA UCA1 Promotes Migration and Invasion in Pancreatic Cancer Cells via the Hippo Pathway. Biochimica et Biophysica Acta: Molecular Basis of Disease, 1864, 1770-1782. [Google Scholar] [CrossRef] [PubMed]
[40] Song, S., Yu, W., Lin, S., Zhang, M., et al. (2018) LncRNA ADPGK-AS1 Promotes Pancreatic Cancer Progression through Activating ZEB1-Mediated Epithelial-Mesenchymal Transition. Cancer Biology & Therapy, 19, 573-583. [Google Scholar] [CrossRef] [PubMed]
[41] Thrift, A.P. and El-Serag, H.B. (2020) Burden of Gastric Cancer. Clinical Gastroenterology and Hepatology, 18, 534- 542. [Google Scholar] [CrossRef] [PubMed]
[42] Sano, T. (2017) Gastric Cancer: Asia and the World. Gastric Can-cer, 20, 1-2. [Google Scholar] [CrossRef] [PubMed]
[43] Biagioni, A., Skalamera, I., Peri, S., et al. (2019) Update on Gas-tric Cancer Treatments and Gene Therapies. Cancer and Metastasis Reviews, 38, 537-548. [Google Scholar] [CrossRef] [PubMed]
[44] Yu, J.M., et al. (2015) BCL6 Induces EMT by Promoting the ZEB1-Mediated Transcription Repression of E-Cadherin in Breast Cancer Cells. Cancer Letters, 365, 190-200. [Google Scholar] [CrossRef] [PubMed]
[45] Lv, D., Wang, Y., Li, S., Shao, X. and Jin, Q. (2023) Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer. Molecular Biotechnology, 65, 72-83. [Google Scholar] [CrossRef] [PubMed]
[46] Shuai, Y., Ma, Z., Liu, W., et al. (2020) TEAD4 Modulated LncRNA MNX1-AS1 Contributes to Gastric Cancer Progression Partly through Suppressing BTG2 and Activating BCL2. Molecular Cancer, 19, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[47] Ma, J.X., Yang, Y.L., He, X.Y., et al. (2019) Long Noncoding RNA MNX1-AS1 Overexpression Promotes the Invasion and Metastasis of Gastric Cancer through Repressing CDKN1A. European Review for Medical and Pharmacological Sciences, 23, 4756-4762.
[48] Zhong, C., Xie, Z., Shen, J., Jia, Y. and Duan, S. (2022) LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics. Cells, 11, Article No. 1540. [Google Scholar] [CrossRef] [PubMed]
[49] Zhang, X. and Wu, J. (2021) LINC00665 Promotes Cell Proliferation, Invasion, and Metastasis by Activating the TGF-β Pathway in Gastric Cancer. Pathology—Research and Practice, 224, Article ID: 153492. [Google Scholar] [CrossRef] [PubMed]
[50] Ni, C., Teng, P. and Hu, P. (2020) Effects of ANCR lncRNA on the Biological Behaviors of Lung Cancer Cells A549 and the Mechanism. Translational Cancer Research, 9, 4693-4702. [Google Scholar] [CrossRef] [PubMed]
[51] Li, Z., Dong, M., Fan, D., et al. (2017) LncRNA ANCR Down-Regulation Promotes TGF-β-Induced EMT and Metastasis in Breast Cancer. Oncotarget, 8, 67329-67343. [Google Scholar] [CrossRef] [PubMed]
[52] Yang, Z.Y., Yang, F., Zhang, Y.L., et al. (2017) LncRNA-ANCR Down-Regulation Suppresses Invasion and Migration of Colorectal Cancer Cells by Regulating EZH2 Expression. Can-cer Biomark, 18, 95-104. [Google Scholar] [CrossRef